FDA-approved (specific uses)

Vagus nerve stimulation (VNS)

Vagus nerve stimulation (VNS) involves a small pulse generator implanted under the skin of the chest, connected to the vagus nerve in the neck. It is FDA-approved for adults with chronic or recurrent major depression that has not responded to at least four adequate antidepressant treatments — a small, carefully selected group.

FDA status
Approved for severe, chronic treatment-resistant depression (and epilepsy)
Procedure
Outpatient surgery to implant the device
Timeline
Benefits typically build over months, not days
Coverage
Coverage varies; many plans require extensive documentation

Who VNS is for

VNS is reserved for people with long-running, severe depression that has not responded to multiple medications, therapy, and often ECT. It is not a first-line or rapid treatment — improvement typically develops gradually over several months of stimulation.

What the evidence shows

Long-term studies show a meaningful share of carefully selected patients improve and stay improved over one to two years, though acute response rates in early trials were modest. Because benefits are slow and the device requires surgery, psychiatrists weigh it only after other options are exhausted.

Living with the device

The stimulator is adjusted at office visits. Common side effects include voice changes or hoarseness, throat tingling, and shortness of breath during stimulation, which often lessen over time. The battery eventually needs surgical replacement.

Common questions

Can the device be removed?

The pulse generator can be removed or turned off; the electrode on the nerve is usually left in place. Discuss reversibility with the surgeon.

Is VNS the same as TMS?

No. TMS is non-invasive and done in a clinic chair; VNS is a surgically implanted device for a much smaller group of patients.

This guide is educational and not medical advice. If you are in crisis, call or text 988.

Find a Provider